Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study
Summary
This summary is machine-generated.Radiolabeled monocyte chemoattractant peptide 1 (MCP-1) effectively identifies experimental arterial lesions rich in monocytes and macrophages. This tracer shows promising potential for imaging atherosclerotic plaque development.
Area Of Science
- Cardiovascular Research
- Molecular Imaging
- Immunology
Background
- Monocytes are key players in atheroma formation, migrating to lesion sites guided by chemoattractant signals like monocyte chemoattractant peptide 1 (MCP-1).
- Identifying and quantifying these infiltrating cells is crucial for understanding and diagnosing atherosclerosis.
Purpose Of The Study
- To evaluate the feasibility of using radiolabeled MCP-1 as a molecular imaging tracer for detecting experimental arterial lesions.
- To assess the biodistribution and localization of radiolabeled MCP-1 in animal models of atherosclerosis.
Main Methods
- Rabbits with experimental arterial lesions were injected with iodine-125 labeled MCP-1 ((125)I-MCP-1) and Evans blue dye.
- Vessel biodistribution was analyzed via autoradiography, histology (H&E staining), and immunohistochemistry (RAM-11 antibody).
Main Results
- (125)I-MCP-1 exhibited a short blood clearance half-time (approx. 10 minutes) and localized in the liver, lungs, and kidneys.
- Autoradiography showed significant accumulation of (125)I-MCP-1 in damaged arterial walls (lesion-to-normal vessel ratio up to 45:1).
- Tracer uptake strongly correlated with macrophage density (r=0.85, P<0.0001), particularly in plaque-rich areas.
Conclusions
- Radiolabeled MCP-1 demonstrates effective accumulation in sites of experimental atherosclerotic lesions.
- The tracer's uptake correlates directly with macrophage infiltration, suggesting its utility for imaging monocyte/macrophage-rich lesions.
View abstract on PubMed